Diagnostic Evidence, Detailed Explanation — Transcript
Diagnostic Evidence, Detailed Explanation
The submitted content consists of patient-specific clinical records for Maria Lamantia and broader medical evidence supplements regarding Supraventricular Tachycardia (SVT). Below are the medically relevant data and the source materials indicated.
1. Source Material Identified
The documents indicate the following specific sources of information used to compile the patient’s medical profile:
Imaging Reports: A CT Head Without Contrast from Alameda Health System dated July 8, 2024 [1, 2].Electrocardiography (ECG): Serial readings, including a critical 12-lead ECG and ambulatory ECGs, dating from July 2024 to December 10, 2025 [3-6].Laboratory Data: CBC and iron studies from February 19, 2025, and September 3, 2025; oncology labs from November 24, 2025; and flow cytometry and molecular testing (JAK2/BCR-ABL) from early 2025 [1, 3, 7, 8].Genetic Testing: Invitae hereditary cancer panels (70-gene panel) and reports from direct-to-consumer services (23andMe, Nebula, Sequencing.com) [2, 3, 9].Clinical Summaries: An HL7 CDA encounter summary from John Muir Health (July 20, 2025) and a progress note from an infusion event on November 3, 2025 [1, 10, 11].Wearable Technology: Data derived from Apple Health and Apple Watch monitoring for Heart Rate Variability (HRV), stress, and nocturnal oxygen saturation [12, 13].Reference Guidelines: The 2015 SVT Guideline Data Supplement, which provides evidence-based outcomes for pharmacological and catheter therapies [14, 15].2. Medically Relevant Patient Data
The sources detail a multisystem profile characterized by acute cardiovascular instability and chronic hematologic and neurological concerns.
Cardiovascular and Respiratory Data
Emergent Electrical Instability: A malignant Long QT phenotype with a peak QTc $\geq$ 612 ms (documented as high as 617 ms in December 2025) [3, 5, 16]. This places the patient at imminent risk for Torsades de Pointes (TdP) and Sudden Cardiac Death (SCD) [5, 17, 18].Hemodynamic Stress: Persistent Stage 1-2 Hypertension (e.g., 166/97 mmHg) and signs of high-output strain with a heart rate of 107–118 bpm [3, 5, 13, 19].Arrhythmias: Documented episodes of Paroxysmal Atrial Fibrillation (AFib), Non-sustained Ventricular Tachycardia (NSVT), and frequent premature ventricular contractions (PVCs) [1, 3, 17].Respiratory Compromise: Resting hypoxemia (SpO₂ 89%) and tachypnea (24 bpm), with suspected Obstructive Sleep Apnea (OSA) given a BMI of 35.6 and reports of nocturnal desaturations [13, 17, 20, 21].Hematologic and Oncologic Data
Severe Iron-Deficiency Anemia: Laboratory confirmed with Ferritin at 6 ng/mL and Hemoglobin falling to 10.9 g/dL [8, 22].Reactive Changes: Persistent leukocytosis (WBC up to 16.43 $\times 10^3/\mu$L) and thrombocytosis (Platelets up to 640 $\times 10^3/\mu$L), which are considered reactive to the anemia and inflammation [3, 7, 8, 22].Malignancy Workup: Investigations for multiple myeloma/plasma cell disorders due to abnormal protein bands, with a bone marrow biopsy scheduled for December 2025 [19]. Molecular tests for primary myeloproliferative disorders were negative [7, 23].Neurological and Metabolic Data
Cerebrovascular Changes: CT findings of mild white matter hypoattenuation indicative of chronic small vessel ischemic disease, which is noted as atypical for the patient’s age (39) [2, 3, 22, 24].Seizure History: A history of seizures, including an episode during a sepsis event in July 2024 that was accompanied by lactic acidosis (4.4 mmol/L) and hepatic injury [1, 3, 20].Metabolic Status: Class II Obesity (BMI 35.11–35.6) and Pre-diabetes (Glucose 114 mg/dL) [1, 3, 20].Allergies and Genetic Risk
Severe Adverse Reaction: A documented contraindication to Ferric Derisomaltose (Monoferric) following an acute allergic reaction involving throat swelling and generalized itching on November 3, 2025 [7, 10, 25, 26].Genetic Panel Results: Clinical-grade testing detected no pathogenic variants or variants of uncertain significance (VUS) across 70 genes, despite a significant multi-generational family history of kidney, colon, pancreatic, and stomach cancers [2, 3, 9].*
Analogy for Cardiovascular State:
The patient’s heart is currently like a house with both faulty wiring and a failing power grid. The Long QT interval (the wiring) is prone to “short-circuiting” into a deadly rhythm, while the chronic hypertension and anemia (the grid) keep the entire system under a constant, high-pressure load that prevents it from ever cooling down.
Created with Chunk